On October 5, 2026, Italy's state cannabis producer in Florence made its online portal the only accepted channel for purchase requests for medical cannabis. It's a small administrative change. It also shows how tightly the Italian state still controls every gram of medical flower that reaches a patient, including the flower it buys from abroad.
Exporting cannabis to Italy from Canada is legal, but there's no open wholesale market to sell into. Canadian Licensed Producers reach Italian pharmacies through two routes: public supply tenders run by the Ministry of Defence's Agenzia Industrie Difesa, or an Italian importer holding a Ministry of Health authorisation. Both routes require EU-GMP manufacture, GACP cultivation and an EU-based importer to certify each batch.
The permit sequence still starts with Health Canada. The harder part is the Italian technical file, which is where most Canadian bids have failed.
How Italy's medical cannabis supply chain works
Italy legalised medical cannabis in 2007, and the Ministerial Decree of 9 November 2015 set the rules that still shape the market. That decree named the Ministry of Health as Italy's state cannabis agency under the INCB framework of the 1961 Single Convention on Narcotic Drugs, and it authorised production at the Stabilimento Chimico Farmaceutico Militare (SCFM) in Florence, a military pharmaceutical plant.
Patients don't buy packaged flower off a shelf. A physician writes a prescription, and a pharmacy prepares a magistral preparation from standardised cannabis flower. The national health service (SSN) covers specific indications set out in the 2015 decree, with regional rules on top.
Domestic supply has never matched demand
SCFM produces its own varieties, such as FM-2, but domestic output has fallen short for years. Italian Ministry of Health figures cited by Bedrocan put dispensed medical cannabis, including extracts, at more than 1.4 tonnes in 2023. The gap is filled by imports: historically Dutch product supplied through the Office of Medicinal Cannabis, then Canadian and other foreign flower bought through public tenders.
Private import authorisations are new and rare
By 2019, only six private wholesalers held import authorisations, they were limited to Dutch product, and the Ministry of Health had signalled it didn't plan to issue more. That changed on June 24, 2025, when Tilray's Italian subsidiary FL Group became the first company authorised to import and distribute its own branded medical flower, sourced from its EU-GMP facility in Portugal. One branded-flower authorisation is a short track record, so plan for the private route to take longer to approve than a tender bid.
Two routes into Italy for Canadian cannabis flower
A Canadian LP has two realistic ways to supply Italian patients. They differ in who signs the contract, how prices are set, and how much paperwork lands on the producer.
| Factor | Route A: AID public tender | Route B: Authorised Italian importer |
|---|---|---|
| Buyer | SCFM Florence, via Agenzia Industrie Difesa | Ministry-authorised Italian distributor |
| Contract basis | Public procurement under Italian code | Commercial supply agreement |
| Product identity | Spec-driven lots by THC/CBD profile | Distributor-branded or LP-branded flower |
| Language | Tender documents mostly in Italian | Negotiated with partner |
| Price discovery | Published reference price per lot | Private negotiation |
| Main risk | Disqualification on technical paperwork | Few authorised importers exist |
Route A: AID public tenders
Agenzia Industrie Difesa runs accelerated open tenders when SCFM needs stock. The first, launched in late 2017, sought 100 kg split across three THC and CBD lots with a budget of EUR 573,770. Aurora's German subsidiary won it at an average of EUR 3.2 per gram. By June 2019, roughly 18 months later, AID was back with a 400 kg tender at a EUR 1.52 million reference price, or about EUR 3.8 per gram. Aurora was the only winner because competing bidders were disqualified for failing the technical requirements.
Volume quadrupled inside 18 months while the number of qualified bidders fell to one.
Route B: an authorised Italian importer
The FL Group authorisation shows the Ministry will approve a private importer bringing branded EU-GMP flower into Italian pharmacies. For a Canadian LP without its own Italian entity, this route means partnering with a distributor that already holds, or is applying for, that authorisation. Your job is to make the partner's dossier easy to approve.
Most Canadian LPs should start with Route B conversations and use published tender specifications as their quality benchmark.
Italian tender specifications and where Canadian LPs fail
The 2019 AID tender specification, summarised by law firm A&O Shearman, is the best public baseline for what Italy expects. It required:
- Plants reproduced by agamic (clonal) propagation for uniform, standardised product
- Starting material cultivated and harvested under GACP
- No treatment with pesticides or fumigants
- Active substance manufactured under EU-GMP by a licensed producer
- Compliance with the general monograph of the European Pharmacopoeia
- Import into the EU by an authorised company that tests and certifies each batch
Bidders also declare minimum turnover in each of the last three financial years at least equal to the value of the lots they bid on, plus the moral and anti-mafia requirements that apply to every Italian public tender. An August 2022 AID tender for balanced THC and CBD flower went further on logistics. Its offer form required the price to include import costs, transport to SCFM, irradiation and packaging design, with delivery due within 60 days of receiving the Italian permit to import.
Friction point 1: the pesticide clause
The Cannabis Regulations allow Canadian LPs to use pest control products registered for cannabis. The Italian specification asks for material never treated with pesticides at all. A clean residue panel won't settle that question, because the clause covers treatment history and residue testing can't show history. Your IPM records need to prove a biological-only programme for the specific batches you offer.
Friction point 2: the EU certification step
A Canadian facility can't release a batch into Italy by itself. An EU importer holding a manufacturing and import authorisation must test the flower and have its Qualified Person certify it. If you haven't mapped how EU QP batch release works with your partner, your 60-day delivery clock starts with a gap in it.
Friction point 3: irradiation and the 60-day window
Pricing irradiation into a fixed tender offer means you need the treatment route, the dose records and the validated microbial result before you bid. Sixty days from permit to Florence leaves no time to discover your irradiation partner's lead time.
A Canadian LP without an EU-GMP certificate and a contracted EU importer shouldn't bid on an AID tender. The technical file will disqualify it before price is ever compared.
The Canada to Italy export path: 4 steps
Whichever route you take, the permit sequence follows the same two-permit chain used for every medical cannabis export under the Cannabis Act.
- Qualify the facility. Hold a current EU-GMP certificate for the Canadian site, issued after inspection by an EU authority, and GACP-aligned cultivation records. Our guide to EU-GMP certification for a Canadian cannabis facility covers that process.
- Secure the Italian import authorisation. The Italian importing party, whether SCFM through a tender or an authorised distributor, obtains the import permit from the Ministry of Health's Central Narcotics Office.
- Apply for the Health Canada export permit. Health Canada requires the importing country's permit before it issues an export permit, and each permit covers a specific quantity and shipment.
- Ship, certify and deliver. Flower moves to the EU importer for testing and QP certification, then on to the Italian buyer within the contract's delivery window.
Most delays sit between steps 2 and 3. Italian permit timing is outside your control, so the export application, COA package and irradiation booking should be ready before the import permit arrives.
AlphaLeaf is a Montreal-based Health Canada Licensed Producer of indoor-grown, hand-trimmed cannabis flower built on refined genetics. Our ISO/IEC 17025-tested batch data, full traceability records and export authorisation under the Cannabis Act give Italian importers and EU partners the documentation they need to qualify a Canadian source.
Italy's buyers are few and its specifications are public. Your technical file decides whether you qualify. To discuss supply for the Italian medical channel, contact AlphaLeaf.
Frequently Asked Questions
Can a Canadian Licensed Producer export cannabis to Italy?
Yes. Canadian LPs can supply medical cannabis flower to Italy through public tenders run by Agenzia Industrie Difesa or through an Italian importer authorised by the Ministry of Health. The flower must be produced under EU-GMP, cultivated under GACP and certified by an EU-based importer.
Who buys medical cannabis flower in Italy?
The main buyer is the Stabilimento Chimico Farmaceutico Militare in Florence, which purchases imported flower through Agenzia Industrie Difesa tenders and supplies pharmacies. Since June 2025, the Ministry of Health has also authorised a private importer, FL Group, to import and distribute branded medical flower.
Does Italy require EU-GMP certification for imported cannabis flower?
Yes. Italian tender specifications require the active substance to be manufactured under EU-GMP and imported into the EU by an authorised company that tests and certifies each batch. Competing bidders in the 2019 tender were disqualified for failing its technical requirements.
Do Italian cannabis tenders allow pesticide use?
Past AID tender specifications required starting material that had not been treated with pesticides or fumigants. Canadian LPs that use registered pest control products under the Cannabis Regulations need batch records showing a pesticide-free programme for the flower they offer.
How long does a supplier have to deliver after an Italian tender award?
The August 2022 AID tender set a maximum of 60 days from receipt of the Italian permit to import for delivery to the SCFM warehouse. Suppliers should have the Health Canada export application, COA package and irradiation booking ready before that permit arrives.
How is medical cannabis dispensed to patients in Italy?
A physician prescribes cannabis and a pharmacy prepares a magistral preparation from standardised flower, under rules set by the Ministerial Decree of 9 November 2015. The national health service covers specific indications defined in that decree.
